| [1] |
Cornelis T, Odutayo A, Keunen J, et al. The kidney in normal pregnancy and preeclampsia. Semin Nephrol, 2011, 31(1):4-14.
|
| [2] |
Jeyabalan A, Novak J, Danielson LA, et al. Essential role for vascular gelatinase activity in relaxin-induced renal vasodilation, hyperfiltration, and reduced myogenic reactivity of small arteries. Circ Res, 2003,93(12):1249-1257.
|
| [3] |
Hladunewich MA, Derby GC, Lafayette RA, et al. Effect of L-arginine therapy on the glomerular injury of preeclampsia: a randomized controlled trial. Obstet Gynecol, 2006,107(4):886-895.
|
| [4] |
Zhou CC, Ahmad S, Mi T, et al. Autoantibody from women with preeclampsia induces soluble Fms-like tyrosine kinase-1 production via angiotensin type 1 receptor and calcineurin/nuclear factor of activated T-cells signaling. Hypertension, 2008, 51(4):1010-1019.
|
| [5] |
Anton L, Merrill DC, Neves LA, et al. The uterine placental bed Renin-Angiotensin system in normal and preeclamptic pregnancy. Endocrinology, 2009, 150(9):4316-4325.
|
| [6] |
Jeyabalan A, Conrad KP. Renal function during normal pregnancy and preeclampsia. Front Biosci, 2007,12:2425-2437.
|
| [7] |
Gilbert JS, Babcock SA, Granger JP. Hypertension produced by reduced uterine perfusion in pregnant rats is associated with increased soluble fms-like tyrosine kinase-1 expression. Hypertension, 2007, 50(6):1142-1147.
|
| [8] |
Garovic VD. The role of angiogenic factors in the prediction and diagnosis of preeclampsia superimposed on chronic hypertension. Hypertension, 2012, 59(3):555-557.
|
| [9] |
Crispi F, Llurba E, Dominguez C, et al. Predictive value of angiogenic factors and uterine artery Doppler for early- versus late-onset pre-eclampsia and intrauterine growth restriction. Ultrasound Obstet Gynecol, 2008, 31(3):303-309.
|
| [10] |
Verlohren S, Stepan H, Dechend R. Angiogenic growth factors in the diagnosis and prediction of pre-eclampsia. Clin Sci (Lond), 2012,122(2):43-52.
|
| [11] |
Espinoza J, Romero R, Nien JK, et al. Identification of patients at risk for early onset and/or severe preeclampsia with the use of uterine artery Doppler velocimetry and placental growth factor. Am J Obstet Gynecol, 2007,196(4):326 e321-e313.
|
| [12] |
Stillman IE, Karumanchi SA. The glomerular injury of preeclampsia. J Am Soc Nephrol, 2007,18(8):2281-2284.
|
| [13] |
Maynard SE, Thadhani R. Pregnancy and the kidney. J Am Soc Nephrol, 2009, 20(1):14-22.
|
| [14] |
Mirza FG, Cleary KL. Pre-eclampsia and the kidney. Semin Perinatol, 2009, 33(3):173-178.
|
| [15] |
Fischer MJ. Chronic kidney disease and pregnancy: maternal and fetal outcomes. Adv Chronic Kidney Dis, 2007,14(2):132-145.
|
| [16] |
Benton SJ, Hu Y, Xie F, et al. Angiogenic factors as diagnostic tests for preeclampsia: a performance comparison between two commercial immunoassays. Am J Obstet Gynecol, 2011, 205(5):469 e461-e468.
|
| [17] |
Naresh CN, Hayen A, Craig JC, et al. Day-to-day variability in spot urine protein-creatinine ratio measurements. Am J Kidney Dis, 2012, 60(4):561-566.
|
| [18] |
Brown MA. Pre-eclampsia: Proteinuria in pre-eclampsia-does it matter any more？. Nat Rev Nephrol, 2012, 8(10):563-565.
|
| [19] |
Foster RR, Saleem MA, Mathieson PW, et al. Vascular endothelial growth factor and nephrin interact and reduce apoptosis in human podocytes. Am J Physiol Renal Physiol, 2005, 288(1):F48-F57.
|
| [20] |
Lindheimer MD, Kanter D. Interpreting abnormal proteinuria in pregnancy: the need for a more pathophysiological approach. Obstet Gynecol, 2010,115(2 Pt 1):365-375.
|
| [21] |
Imbasciati E, Gregorini G, Cabiddu G, et al. Pregnancy in CKD stages 3 to 5: fetal and maternal outcomes. Am J Kidney Dis, 2007, 49(6):753-762.
|
| [22] |
Collino F, Bussolati B, Gerbaudo E, et al. Preeclamptic sera induce nephrin shedding from podocytes through endothelin-1 release by endothelial glomerular cells. Am J Physiol Renal Physiol, 2008, 294(5):F1185-F1194.
|
| [23] |
Garovic VD, Wagner SJ, Turner ST, et al. Urinary podocyte excretion as a marker for preeclampsia. Am J Obstet Gynecol, 2007, 196(4):320 e321-e327.
|
| [24] |
Piccoli GB, Attini R, Vasario E, et al. Pregnancy and chronic kidney disease: a challenge in all CKD stages. Clin J Am Soc Nephrol, 2010,5(5):844-855.
|
| [25] |
Phelan ST. Renal disease in pregnancy ambulatory issues. Clin Obstet Gynecol, 2012, 55(3):829-837.
|
| [26] |
Rashid M, Rashid HM. Chronic renal insufficiency in pregnancy. Saudi Med J, 2003, 24(7):709-714.
|
| [27] |
van Pampus MG, Aarnoudse JG. Long-term outcomes after preeclampsia. Clin Obstet Gynecol, 2005, 48(2):489-494.
|
| [28] |
Ruiz-Irastorza G, Khamashta MA. Lupus and pregnancy: ten questions and some answers. Lupus, 2008,17(5):416-420.
|
| [29] |
Egerman RS, Ramsey RD, Kao LW, et al. Hypertensive disease in pregnancies complicated by systemic lupus erythematosus. Am J Obstet Gynecol, 2005,193(5):1676-1679.
|
| [30] |
Seeman T. Hypertension after renal transplantation. Pediatr Nephrol, 2009, 24(5):959-972.
|
| [31] |
Perales-Puchalt A, Vila Vives JM, Lopez Montes J, et al. Pregnancy outcomes after kidney transplantation-immunosuppressive therapy comparison. J Matern Fetal Neonatal Med, 2012, 25(8):1363-1366.
|
| [32] |
Cooper WO, Hernandez-Diaz S, Arbogast PG, et al. Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med, 2006, 354(23):2443-2451.
|
| [33] |
Hladunewich MA, Myers BD, Derby GC, et al. Course of preeclamptic glomerular injury after delivery. Am J Physiol Renal Physiol, 2008, 294(3):F614-F620.
|